Dexcom can amend counterclaim after Abbott partially withdrew infringement claim, UPC The Hague says
MLex Summary: Dexcom can amend its counterclaim in its dispute with Abbott over European Patent 4,070,727, the Unified Patent Court’s Local Division in The Hague said in an order published today....To view the full article, register now.
Already a subscriber? Click here to view full article